denovoMATRIX develops biomimetic coatings and cell culture substrates that provide chemically defined, serum-free environments to improve the reproducibility and quality of stem cell research and cell-based therapy production.
denovoMATRIX GmbH is a Dresden-based life sciences company that develops and manufactures biomimetic coatings and cell culture substrates designed to replicate the human biological environment in vitro. Founded as a spin-off from the Technical University of Dresden, the company utilizes proprietary technology to create chemically defined, serum-free solutions that aim to improve the reproducibility and relevance of cell culture applications. Their product portfolio includes screenMATRIX, a tool for researchers to discover optimal cell culture conditions, and myMATRIX, a line of substrates tailored for the efficient, large-scale cultivation of stem cells, including mesenchymal stromal cells. By providing consistent, animal-free biomaterials, denovoMATRIX addresses critical challenges in cell therapy manufacturing and pharmaceutical research. Their technology helps scientists move beyond traditional, variable cell culture methods, ensuring high-quality cell production that is essential for translating advanced stem cell therapies from laboratory research into clinical applications. The company maintains active research collaborations with academic institutions to further advance its biomaterials for diverse applications in tissue modeling and drug development.